Kavar Capital Partners Group LLC Has $292,000 Position in BlackRock Health Sciences Term Trust (NYSE:BMEZ)

Kavar Capital Partners Group LLC decreased its holdings in BlackRock Health Sciences Term Trust (NYSE:BMEZ) by 34.1% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 20,250 shares of the company’s stock after selling 10,500 shares during the period. Kavar Capital Partners Group LLC’s holdings in BlackRock Health Sciences Term Trust were worth $292,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently made changes to their positions in the business. Brown Brothers Harriman & Co. acquired a new position in shares of BlackRock Health Sciences Term Trust in the third quarter valued at $32,000. K2 Principal Fund L.P. bought a new stake in BlackRock Health Sciences Term Trust in the 3rd quarter valued at $158,000. Dakota Wealth Management grew its stake in shares of BlackRock Health Sciences Term Trust by 23.4% in the third quarter. Dakota Wealth Management now owns 22,509 shares of the company’s stock valued at $357,000 after acquiring an additional 4,267 shares in the last quarter. Jane Street Group LLC acquired a new stake in BlackRock Health Sciences Term Trust in the 3rd quarter worth about $357,000. Finally, Kingswood Wealth Advisors LLC bought a new stake in BlackRock Health Sciences Term Trust in the 4th quarter valued at about $420,000.

BlackRock Health Sciences Term Trust Trading Down 0.1 %

NYSE BMEZ opened at $16.39 on Monday. BlackRock Health Sciences Term Trust has a 1-year low of $14.27 and a 1-year high of $16.59. The company has a 50 day moving average of $15.29 and a 200-day moving average of $15.61.

BlackRock Health Sciences Term Trust Announces Dividend

The firm also recently announced a monthly dividend, which will be paid on Friday, January 31st. Shareholders of record on Wednesday, January 15th will be paid a dividend of $0.1782 per share. This represents a $2.14 annualized dividend and a yield of 13.05%. The ex-dividend date is Wednesday, January 15th.

About BlackRock Health Sciences Term Trust

BlackRock Health Sciences Trust II’s (BMEZ) (the ‘Trust’) investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries.